Top compounds associated with response to SREK1


Feature Type Standardized
Nominal ANOVA
mRNA A-770041 GDSC1000 pan-cancer AAC 0.12 0.03
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.073 0.03
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.076 0.03
mRNA BRD-A86708339 CTRPv2 pan-cancer AAC 0.11 0.03
mRNA etoposide GDSC1000 pan-cancer AAC 0.079 0.03
mRNA GSK461364 CTRPv2 pan-cancer AAC 0.069 0.03
mRNA Ispinesib Mesylate GDSC1000 pan-cancer AAC 0.072 0.03
mRNA S-Trityl-L-cysteine GDSC1000 pan-cancer AAC 0.12 0.03
mRNA BRD-K16147474 CTRPv2 pan-cancer AAC 0.085 0.03
mRNA XAV-939 GDSC1000 pan-cancer AAC 0.078 0.03
Download CSV